Cargando…
Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing
INTRODUCTION: Vancomycin powder (VP) is an antibiotic first introduced in pediatric spinal surgery to prevent surgical site infections (SSI). Recently its topical application was expanded to total hip and knee arthroplasty (THA, TKA) and anterior cruciate ligament reconstruction (ACLR). Toxicity to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374468/ https://www.ncbi.nlm.nih.gov/pubmed/36538161 http://dx.doi.org/10.1007/s00402-022-04721-w |
_version_ | 1785078782635278336 |
---|---|
author | Jacob, Benjamin Wassilew, Georgi von Eisenhart-Rothe, Rüdiger Brodt, Steffen Matziolis, Georg |
author_facet | Jacob, Benjamin Wassilew, Georgi von Eisenhart-Rothe, Rüdiger Brodt, Steffen Matziolis, Georg |
author_sort | Jacob, Benjamin |
collection | PubMed |
description | INTRODUCTION: Vancomycin powder (VP) is an antibiotic first introduced in pediatric spinal surgery to prevent surgical site infections (SSI). Recently its topical application was expanded to total hip and knee arthroplasty (THA, TKA) and anterior cruciate ligament reconstruction (ACLR). Toxicity to cartilage is the subject of current research. The aim of this study was to prove the hypothesis that topical application of VP in TKA does not result in a degeneration of patella cartilage. We propagate that the conversion rate for secondary patella resurfacing is not influenced by its use. MATERIALS AND METHODS: Between 2014 and 2021, 4292 joints were included in this monocentric retrospective cohort study. All patients underwent TKA without primary patella resurfacing. After a change of the procedure in the hospital, one group (VPG) was administered VP intraoperatively. The other group (nVPG) received no VP during surgery (nVPG). The remaining perioperative procedure was constant over the investigation period. Conversion rates for secondary patella resurfacing for both groups were determined without making distinctions in the indication. A second cohort was composed of patients presenting for follow-up examination 12 months after TKA and included 210 joints. Retrospective radiographic evaluations were performed preoperatively, before discharge and at follow-up examination. Patella axial radiographs were analyzed for patella tracking (lateral patellar tilt, patellar displacement) and patella degeneration (Sperner classification, patellofemoral joint space). RESULTS: There was no significant difference in the conversion rate for secondary patella resurfacing (4.24% VPG, 4.97% nVPG). Patella tracking and patella degeneration did not differ significantly between both groups. CONCLUSIONS: The topical application of VP does not influence the conversion rate for secondary patella resurfacing. Moreover, it does not result in a degeneration of patella cartilage in TK. LEVEL OF EVIDENCE: Retrospective case series, Level III. |
format | Online Article Text |
id | pubmed-10374468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103744682023-07-29 Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing Jacob, Benjamin Wassilew, Georgi von Eisenhart-Rothe, Rüdiger Brodt, Steffen Matziolis, Georg Arch Orthop Trauma Surg Knee Arthroplasty INTRODUCTION: Vancomycin powder (VP) is an antibiotic first introduced in pediatric spinal surgery to prevent surgical site infections (SSI). Recently its topical application was expanded to total hip and knee arthroplasty (THA, TKA) and anterior cruciate ligament reconstruction (ACLR). Toxicity to cartilage is the subject of current research. The aim of this study was to prove the hypothesis that topical application of VP in TKA does not result in a degeneration of patella cartilage. We propagate that the conversion rate for secondary patella resurfacing is not influenced by its use. MATERIALS AND METHODS: Between 2014 and 2021, 4292 joints were included in this monocentric retrospective cohort study. All patients underwent TKA without primary patella resurfacing. After a change of the procedure in the hospital, one group (VPG) was administered VP intraoperatively. The other group (nVPG) received no VP during surgery (nVPG). The remaining perioperative procedure was constant over the investigation period. Conversion rates for secondary patella resurfacing for both groups were determined without making distinctions in the indication. A second cohort was composed of patients presenting for follow-up examination 12 months after TKA and included 210 joints. Retrospective radiographic evaluations were performed preoperatively, before discharge and at follow-up examination. Patella axial radiographs were analyzed for patella tracking (lateral patellar tilt, patellar displacement) and patella degeneration (Sperner classification, patellofemoral joint space). RESULTS: There was no significant difference in the conversion rate for secondary patella resurfacing (4.24% VPG, 4.97% nVPG). Patella tracking and patella degeneration did not differ significantly between both groups. CONCLUSIONS: The topical application of VP does not influence the conversion rate for secondary patella resurfacing. Moreover, it does not result in a degeneration of patella cartilage in TK. LEVEL OF EVIDENCE: Retrospective case series, Level III. Springer Berlin Heidelberg 2022-12-20 2023 /pmc/articles/PMC10374468/ /pubmed/36538161 http://dx.doi.org/10.1007/s00402-022-04721-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Knee Arthroplasty Jacob, Benjamin Wassilew, Georgi von Eisenhart-Rothe, Rüdiger Brodt, Steffen Matziolis, Georg Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing |
title | Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing |
title_full | Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing |
title_fullStr | Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing |
title_full_unstemmed | Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing |
title_short | Topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing |
title_sort | topical vancomycin powder does not affect patella cartilage degeneration in primary total knee arthroplasty and conversion rate for secondary patella resurfacing |
topic | Knee Arthroplasty |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374468/ https://www.ncbi.nlm.nih.gov/pubmed/36538161 http://dx.doi.org/10.1007/s00402-022-04721-w |
work_keys_str_mv | AT jacobbenjamin topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing AT wassilewgeorgi topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing AT voneisenhartrotherudiger topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing AT brodtsteffen topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing AT matziolisgeorg topicalvancomycinpowderdoesnotaffectpatellacartilagedegenerationinprimarytotalkneearthroplastyandconversionrateforsecondarypatellaresurfacing |